{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:06:28Z","timestamp":1790625988640,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","journalofhospitalinfection.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hospital Infection"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jhin.2017.02.006","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T16:45:43Z","timestamp":1486658743000},"page":"35-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Attributable mortality of hospital-acquired bloodstream infections in Ireland"],"prefix":"10.1016","volume":"96","author":[{"given":"M.","family":"Brady","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Oza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Cunney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhin.2017.02.006_bib1","doi-asserted-by":"publisher","first-page":"R100","DOI":"10.1186\/cc10114","article-title":"Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality","volume":"15","author":"Prowle","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.jhin.2017.02.006_bib2","series-title":"Point prevalence survey of hospital acquired infections & antimicrobial use in european acute care hospitals: May 2012 Republic of Ireland National Report","author":"Burns","year":"2012"},{"key":"10.1016\/j.jhin.2017.02.006_bib3","series-title":"Annual report 2012","author":"Health Protection Surveillance Centre","year":"2013"},{"key":"10.1016\/j.jhin.2017.02.006_bib4","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s10096-016-2727-4","article-title":"Klebsiella pneumoniae bloodstream infection, antimicrobial resistance and consumption trends in Ireland: 2008 to 2013","volume":"35","author":"Brady","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jhin.2017.02.006_bib5","series-title":"Antibiotic resistance threats in the United States","author":"Centers for Disease Control and Prevention","year":"2013"},{"key":"10.1016\/j.jhin.2017.02.006_bib6","unstructured":"European Centres for Disease Prevention and Control\u2013European Medicines Agency. ECDC-EMEA Joint Technical Report. The bacterial challenge: time to react. Stockholm: ECDC-EMEA; 2009."},{"key":"10.1016\/j.jhin.2017.02.006_bib7","series-title":"Enhanced bacteraemia surveillance in Ireland, 2004 and 2005","author":"Oza","year":"2006"},{"key":"10.1016\/j.jhin.2017.02.006_bib8","doi-asserted-by":"publisher","unstructured":"Wiley MM. Using HIPE data as a research and planning tool: limitations and opportunities: a response. Ir J Med Sci;174:40\u201345; discussion 52\u201357.","DOI":"10.1007\/BF03169130"},{"key":"10.1016\/j.jhin.2017.02.006_bib9","series-title":"Statistical methods for rates and proportions","author":"Fleiss","year":"1981"},{"key":"10.1016\/j.jhin.2017.02.006_bib10","first-page":"225","article-title":"Sample size calculation in epidemiological studies","volume":"7","author":"Kasiulevi\u010dius","year":"2006","journal-title":"Gerontologija"},{"key":"10.1016\/j.jhin.2017.02.006_bib11","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1093\/ije\/31.6.1246","article-title":"Probabilistic record linkage and a method to calculate the positive predictive value","volume":"31","author":"Blakely","year":"2002","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jhin.2017.02.006_bib12","doi-asserted-by":"publisher","first-page":"883.e1","DOI":"10.1016\/j.jclinepi.2006.11.021","article-title":"Probabilistic record linkage is a valid and transparent tool to combine databases without a patient identification number","volume":"60","author":"Meray","year":"2007","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jhin.2017.02.006_bib13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jclinepi.2010.05.008","article-title":"Results from simulated data sets: probabilistic record linkage outperforms deterministic record linkage","volume":"645","author":"Tromp","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jhin.2017.02.006_bib14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jsat.2008.05.004","article-title":"Impact of record-linkage methodology on performance indicators and multivariate relationships","volume":"361","author":"Campbell","year":"2009","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.jhin.2017.02.006_bib15","first-page":"875","article-title":"Accuracy of probabilistic linkage applied to health databases: systematic review","volume":"435","author":"Artmann","year":"2009","journal-title":"Rev Sa\u00fade P\u00fablica"},{"key":"10.1016\/j.jhin.2017.02.006_bib16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/tid.12175","article-title":"Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations","volume":"161","author":"Blennow","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jhin.2017.02.006_bib17","first-page":"21","article-title":"Morbidity and mortality associated with primary and catheter-related bloodstream infections in critically ill patients","volume":"26","author":"Olaechea","year":"2013","journal-title":"Rev Espanol Quimioter"},{"key":"10.1016\/j.jhin.2017.02.006_bib18","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.bjid.2012.10.001","article-title":"Healthcare-associated Staphylococcus aureus bloodstream infection: length of stay, attributable mortality, and additional direct costs","volume":"166","author":"Primo","year":"2012","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.jhin.2017.02.006_bib19","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/1472-6963-12-432","article-title":"Long-term survival and healthcare utilization outcomes attributable to sepsis and pneumonia","volume":"12","author":"Dick","year":"2012","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jhin.2017.02.006_bib20","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1111\/j.1399-6576.2008.01763.x","article-title":"Risk factors and outcome in ICU-acquired infections","volume":"52","author":"Magnason","year":"2008","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jhin.2017.02.006_bib21","doi-asserted-by":"publisher","first-page":"O318","DOI":"10.1111\/1469-0691.12407","article-title":"Inpatient costs, mortality and 30-day re-admission in patients with central-line-associated bloodstream infections","volume":"20","author":"Stevens","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2017.02.006_bib22","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/cid\/cis552","article-title":"Costs of healthcare and\u00a0community and community-associated infections with antimicrobial-resistant versus antimicrobial susceptible organisms","volume":"556","author":"Neidell","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2017.02.006_bib23","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/jac\/dkq412","article-title":"Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins","volume":"662","author":"De Kraker","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2017.02.006_bib24","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s15010-014-0670-9","article-title":"Bloodstream infection due to extended-spectrum beta-lactamase (ESBL)-positive K.\u00a0pneumoniae and E.\u00a0coli: an analysis of the disease burden in a large cohort","volume":"426","author":"Leistner","year":"2014","journal-title":"Infection"},{"key":"10.1016\/j.jhin.2017.02.006_bib25","series-title":"Carbapenem use in hospitals has doubled in the last five years","author":"Oza","year":"2014"},{"key":"10.1016\/j.jhin.2017.02.006_bib26","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1086\/605922","article-title":"Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia","volume":"3010","author":"Borer","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jhin.2017.02.006_bib27","doi-asserted-by":"publisher","first-page":"484","DOI":"10.7326\/0003-4819-135-7-200110020-00007","article-title":"Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia: a prospective multicenter study","volume":"1357","author":"Vergis","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhin.2017.02.006_bib28","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1001\/archinte.158.5.522","article-title":"Enterococcus faecium bacteremia: does vancomycin resistance make a difference?","volume":"158","author":"Stosor","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jhin.2017.02.006_bib29","series-title":"Guidelines for the prevention and control of multidrug resistant organisms (MDRO) excluding MRSA in the healthcare setting","year":"2014"},{"key":"10.1016\/j.jhin.2017.02.006_bib30","series-title":"Antimicrobial resistance surveillance in Europe 2014","author":"European Centres for Disease Prevention and Control","year":"2015"}],"container-title":["Journal of Hospital Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670117300920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670117300920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T12:22:39Z","timestamp":1536063759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195670117300920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0195670117300920"],"URL":"https:\/\/doi.org\/10.1016\/j.jhin.2017.02.006","relation":{},"ISSN":["0195-6701"],"issn-type":[{"value":"0195-6701","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Attributable mortality of hospital-acquired bloodstream infections in Ireland","name":"articletitle","label":"Article Title"},{"value":"Journal of Hospital Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhin.2017.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}